<p><strong>亨斯邁公司</strong>（NYSE:HUN）的股東無疑會高興地看到，股價在過去一個月上漲了 27%，儘管它仍在努力彌補最近失去的地盤。然而，並不是所有股東都會感到歡欣鼓舞，因為股價在過去一年中仍然下跌了令人失望的 47%。</p>
<p>儘管股價大幅反彈，但考慮到美國化工行業約一半的公司市銷率（或稱&#34;P/S&#34;）超過 1.1 倍，您仍然可以將亨斯邁視為一個穩健的投資機會，其市銷率為 0.3 倍。不過，僅僅將市銷率視為表面值並不明智，因為可能有解釋説明其受限的原因。</p>
<p>特朗普承諾要&#34;釋放&#34;美國的石油和天然氣，這 15 只美國股票的發展有望受益。</p>
<p>查看我們對亨斯邁的最新分析</p>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/asset/chart/165298-ps-multiple-vs-industry-1-dark-2/1764505746406?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/asset/chart/165298-ps-multiple-vs-industry-1-dark-2/1764505746406"/></p>
<p>NYSE:HUN 市銷率與行業比較 2025 年 11 月 30 日</p>
<h3>亨斯邁的表現如何</h3>
<p>儘管行業最近經歷了收入增長，但亨斯邁的收入卻出現了下滑，這並不理想。也許市銷率之所以保持低位，是因為投資者認為強勁的收入增長前景並不在眼前。如果是這樣，那麼現有股東可能會對股價未來的走勢感到失望。</p>
<p>想知道分析師如何看待亨斯邁的未來與行業的對比嗎？那麼我們的 <strong>免費</strong> 報告是一個很好的起點。</p>
<h2>收入預測是否與低市銷率相符？</h2>
<p>您唯一會真正感到舒適的情況是，當公司的增長預計將落後於行業時，市銷率低至亨斯邁的水平。</p>
<p>首先回顧一下，去年公司的收入增長並不令人興奮，出現了令人失望的 3.5% 的下降。這意味着在更長的時間內，收入也出現了下滑，過去三年總收入下降了 32%。因此，不幸的是，我們必須承認公司在這段時間內未能有效地增長收入。</p>
<p>展望未來，分析師預計明年將實現 1.1% 的增長。這顯然低於更廣泛行業的 5.5% 的增長預測。</p>
<p>鑑於此，亨斯邁的市銷率低於大多數其他公司是可以理解的。似乎大多數投資者預計未來增長有限，因此只願意為該股票支付較低的價格。</p>
<h2>亨斯邁的市銷率對投資者意味着什麼？</h2>
<p>最新的股價飆升並不足以將亨斯邁的市銷率拉近行業中位數。雖然市銷率不應成為您是否購買股票的決定性因素，但它是收入預期的一個相當有效的晴雨表。</p>
<p>我們已經確定亨斯邁維持其低市銷率的原因在於其預測增長低於更廣泛行業的預期。股東對公司收入前景的悲觀情緒似乎是導致市銷率低迷的主要原因。公司需要改變運勢，以證明未來市銷率的上升是合理的。</p>
<p>我們不想過於潑冷水，但我們確實發現了 <strong>亨斯邁的 2 個警告信號</strong>（其中 1 個讓我們感到不安！）您需要注意。</p>
<p>當然，<strong>盈利能力強且有良好盈利增長曆史的公司通常是更安全的投資</strong>。因此，您可能希望查看這份 <strong>免費</strong> 的其他公司集合，這些公司具有合理的市盈率並且盈利增長強勁。</p>

亨斯邁

<p>亨斯邁公司的股票最近上漲了 27%，但其市銷率仍然較低，僅為 0.3 倍，而行業平均為 1.1 倍。儘管股價上漲，亨斯邁的收入在三年內下降了 32%，預計明年的增長僅為 1.1%，低於行業的 5.5%。由於收入前景疲弱，投資者保持謹慎，這影響了股票的估值</p>

<p><strong>Huntsman Corporation</strong> (NYSE:HUN) shareholders are no doubt pleased to see that the share price has bounced 27% in the last month, although it is still struggling to make up recently lost ground. Not all shareholders will be feeling jubilant, since the share price is still down a very disappointing 47% in the last twelve months.</p>
<div class="lb-trans"><p><strong>亨斯邁公司</strong>（NYSE:HUN）的股東無疑會高興地看到，股價在過去一個月上漲了 27%，儘管它仍在努力彌補最近失去的地盤。然而，並不是所有股東都會感到歡欣鼓舞，因為股價在過去一年中仍然下跌了令人失望的 47%。</p>
</div><p>In spite of the firm bounce in price, considering around half the companies operating in the United States' Chemicals industry have price-to-sales ratios (or &#34;P/S&#34;) above 1.1x, you may still consider Huntsman as an solid investment opportunity with its 0.3x P/S ratio. Although, it's not wise to just take the P/S at face value as there may be an explanation why it's limited.</p>
<div class="lb-trans"><p>儘管股價大幅反彈，但考慮到美國化工行業約一半的公司市銷率（或稱&#34;P/S&#34;）超過 1.1 倍，您仍然可以將亨斯邁視為一個穩健的投資機會，其市銷率為 0.3 倍。不過，僅僅將市銷率視為表面值並不明智，因為可能有解釋説明其受限的原因。</p>
</div><p>Trump has pledged to &#34;unleash&#34; American oil and gas and these 15 US stocks have developments that are poised to benefit.</p>
<div class="lb-trans"><p>特朗普承諾要&#34;釋放&#34;美國的石油和天然氣，這 15 只美國股票的發展有望受益。</p>
</div><p>See our latest analysis for Huntsman</p>
<div class="lb-trans"><p>查看我們對亨斯邁的最新分析</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/asset/chart/165298-ps-multiple-vs-industry-1-dark-2/1764505746406" alt="" original-src="https://images.simplywall.st/asset/chart/165298-ps-multiple-vs-industry-1-dark-2/1764505746406"/></p>
<p>NYSE:HUN Price to Sales Ratio vs Industry November 30th 2025</p>
<div class="lb-trans"><p>NYSE:HUN 市銷率與行業比較 2025 年 11 月 30 日</p>
</div><h3>How Huntsman Has Been Performing</h3>
<div class="lb-trans"><h3>亨斯邁的表現如何</h3>
</div><p>While the industry has experienced revenue growth lately, Huntsman's revenue has gone into reverse gear, which is not great. Perhaps the P/S remains low as investors think the prospects of strong revenue growth aren't on the horizon. If this is the case, then existing shareholders will probably struggle to get excited about the future direction of the share price.</p>
<div class="lb-trans"><p>儘管行業最近經歷了收入增長，但亨斯邁的收入卻出現了下滑，這並不理想。也許市銷率之所以保持低位，是因為投資者認為強勁的收入增長前景並不在眼前。如果是這樣，那麼現有股東可能會對股價未來的走勢感到失望。</p>
</div><p>Keen to find out how analysts think Huntsman's future stacks up against the industry? In that case, our <strong>free</strong> report is a great place to start.</p>
<div class="lb-trans"><p>想知道分析師如何看待亨斯邁的未來與行業的對比嗎？那麼我們的 <strong>免費</strong> 報告是一個很好的起點。</p>
</div><h2>Do Revenue Forecasts Match The Low P/S Ratio?</h2>
<div class="lb-trans"><h2>收入預測是否與低市銷率相符？</h2>
</div><p>The only time you'd be truly comfortable seeing a P/S as low as Huntsman's is when the company's growth is on track to lag the industry.</p>
<div class="lb-trans"><p>您唯一會真正感到舒適的情況是，當公司的增長預計將落後於行業時，市銷率低至亨斯邁的水平。</p>
</div><p>Taking a look back first, the company's revenue growth last year wasn't something to get excited about as it posted a disappointing decline of 3.5%. This means it has also seen a slide in revenue over the longer-term as revenue is down 32% in total over the last three years. So unfortunately, we have to acknowledge that the company has not done a great job of growing revenue over that time.</p>
<div class="lb-trans"><p>首先回顧一下，去年公司的收入增長並不令人興奮，出現了令人失望的 3.5% 的下降。這意味着在更長的時間內，收入也出現了下滑，過去三年總收入下降了 32%。因此，不幸的是，我們必須承認公司在這段時間內未能有效地增長收入。</p>
</div><p>Turning to the outlook, the next year should generate growth of 1.1% as estimated by the analysts watching the company. That's shaping up to be materially lower than the 5.5% growth forecast for the broader industry.</p>
<div class="lb-trans"><p>展望未來，分析師預計明年將實現 1.1% 的增長。這顯然低於更廣泛行業的 5.5% 的增長預測。</p>
</div><p>In light of this, it's understandable that Huntsman's P/S sits below the majority of other companies. It seems most investors are expecting to see limited future growth and are only willing to pay a reduced amount for the stock.</p>
<div class="lb-trans"><p>鑑於此，亨斯邁的市銷率低於大多數其他公司是可以理解的。似乎大多數投資者預計未來增長有限，因此只願意為該股票支付較低的價格。</p>
</div><h2>What Does Huntsman's P/S Mean For Investors?</h2>
<div class="lb-trans"><h2>亨斯邁的市銷率對投資者意味着什麼？</h2>
</div><p>The latest share price surge wasn't enough to lift Huntsman's P/S close to the industry median. While the price-to-sales ratio shouldn't be the defining factor in whether you buy a stock or not, it's quite a capable barometer of revenue expectations.</p>
<div class="lb-trans"><p>最新的股價飆升並不足以將亨斯邁的市銷率拉近行業中位數。雖然市銷率不應成為您是否購買股票的決定性因素，但它是收入預期的一個相當有效的晴雨表。</p>
</div><p>We've established that Huntsman maintains its low P/S on the weakness of its forecast growth being lower than the wider industry, as expected. Shareholders' pessimism on the revenue prospects for the company seems to be the main contributor to the depressed P/S. The company will need a change of fortune to justify the P/S rising higher in the future.</p>
<div class="lb-trans"><p>我們已經確定亨斯邁維持其低市銷率的原因在於其預測增長低於更廣泛行業的預期。股東對公司收入前景的悲觀情緒似乎是導致市銷率低迷的主要原因。公司需要改變運勢，以證明未來市銷率的上升是合理的。</p>
</div><p>We don't want to rain on the parade too much, but we did also find <strong>2 warning signs for Huntsman</strong> (1 doesn't sit too well with us!) that you need to be mindful of.</p>
<div class="lb-trans"><p>我們不想過於潑冷水，但我們確實發現了 <strong>亨斯邁的 2 個警告信號</strong>（其中 1 個讓我們感到不安！）您需要注意。</p>
</div><p>Of course, <strong>profitable companies with a history of great earnings growth are generally safer bets</strong>. So you may wish to see this <strong>free</strong> collection of other companies that have reasonable P/E ratios and have grown earnings strongly.</p>
<div class="lb-trans"><p>當然，<strong>盈利能力強且有良好盈利增長曆史的公司通常是更安全的投資</strong>。因此，您可能希望查看這份 <strong>免費</strong> 的其他公司集合，這些公司具有合理的市盈率並且盈利增長強勁。</p>
</div>

亨斯邁公司（NYSE:HUN）股票上漲 27% 是否合理，需要在此之前提高收入